Fund 13F filing

Qube Research added $73.8M of Regeneron Pharmaceuticals, Inc. (REGN) stock

SEC Form 13F · Filed Aug 14, 2026

Qube Research added $73.8M of Regeneron Pharmaceuticals, Inc. (REGN) stock in the quarter ending Jun 30, 2026, per a 13F filed Aug 14, 2026.

A 13F shows holdings at quarter end, so the exact trade dates are not disclosed.

Bought

Regeneron Pharmaceuticals, Inc.

Value

$73.8M

More REGN insider and Congress trades

Share this trade

From a public SEC Form 13F, linked above. Not investment advice, and not a recommendation to buy or sell.